Antiretroviral Treatment Simplification With 2-Drug Regimens: Impact of Transmitted Drug Resistance Mutations.
Autor: | Kessler HH; Research Unit Molecular Diagnostics, Diagnostic and Research Center for Molecular Biomedicine, Medical University of Graz, Graz, Austria., Stelzl E; Research Unit Molecular Diagnostics, Diagnostic and Research Center for Molecular Biomedicine, Medical University of Graz, Graz, Austria., Blažič A; Research Unit Molecular Diagnostics, Diagnostic and Research Center for Molecular Biomedicine, Medical University of Graz, Graz, Austria., Mehta SR; Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA.; Department of Medicine, San Diego VA Medical Center, San Diego, California, USA., Benezeder AS; Research Unit Molecular Diagnostics, Diagnostic and Research Center for Molecular Biomedicine, Medical University of Graz, Graz, Austria., Genger-Hackl C; Department of Gastroenterology and Infectious Diseases, Academic Hospital Graz II, Graz, Austria., Santner BI; Research Unit Molecular Diagnostics, Diagnostic and Research Center for Molecular Biomedicine, Medical University of Graz, Graz, Austria., Chaillon A; Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA., Hoenigl M; Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California, USA.; Division of Pulmonology and Section of Infectious Diseases, Medical University of Graz, Graz, Austria. |
---|---|
Jazyk: | angličtina |
Zdroj: | Open forum infectious diseases [Open Forum Infect Dis] 2019 Dec 18; Vol. 7 (1), pp. ofz535. Date of Electronic Publication: 2019 Dec 18 (Print Publication: 2020). |
DOI: | 10.1093/ofid/ofz535 |
Abstrakt: | The frequency of clinically relevant transmitted drug resistance mutations (DRMs) against drugs used for 2-drug regimens was 15.6%, but only 2% were not eligible for 1 or more 2-drug regimens. More than 50% of patients harboring any clinically relevant DRMs were found to be part of genetic transmission clusters. (© The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |